Old API Wind-down Ltd - Ordinary Shares ARLZQ

Aralez Acquire United States and Canadian Right to Zontivity

[Bigboyone]

This in a nice deal from Merck, for $25 Mil..
The Aralez website was not letting me in, with Kutato's Header.

[Bigboyone]

  -Acquired ZONTIVITY ® in the U.S. and Canada -   -Long-range market exclusivity through regulatory exclusivity and intellectual property protection- MISSISSAUGA, Ontario , Sept. 7, 2016 /CNW/ -- Aralez Pharmaceuticals Inc. (ARLZ) (ARZ.TO), a global specialty pharmaceutical company, today announced that it acquired the U.S. and Canadian rights to

[kuatolives]

Can anyone find any sales data on this? Can't seem to find any. Would assume its somewhere in the $5-15M a year range judging by the deal price.

[GoldenDilemma]

Based on some preliminary DD, the drug was a flop largely due to Merck's lack of dilligence for having a competent sales force behind it. Though, I imagine if it is going to be pushed alongside Yosprala/etc, and ARLZ sales force is active and focused in this respect, it may do better. I will read more on the science of it. 

[Bigboyone]

What I have been able to find is Zontivity. (2.08mg).or another name "VORAPAXAR".. is about $300 bucks (US) give or take for a bottle of aprox 30 tabs. Seems a high price, there where speacialty coupons given to hard ship cases by Merck. Maybe our new team can do somthing with it? I want to think possitive-

[90guppy]

Next one is Cardiome...just my bet